HAEM5:Adult T-cell leukaemia/lymphoma: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
Sumire Kitahara, MD | |||
Cedars-Sinai Medical Center | |||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||
| Line 29: | Line 29: | ||
|- | |- | ||
|Subtype(s) | |Subtype(s) | ||
|Adult T-cell leukaemia/lymphoma | |Adult T-cell leukaemia/lymphoma (ATLL) | ||
Smouldering ATLL | |||
Chronic ATLL | |||
Lymphoma ATLL | |||
Acute ATLL | |||
|} | |} | ||